IMM, or immune-mediated myositis, is an autoimmune disease in horses that causes rapid and severe muscle wasting along the topline and hindquarters. It can strip away up to 40% of a horse’s muscle mass in as little as 48 hours, leaving an otherwise healthy-looking animal visibly gaunt across the back, loin, and gluteal muscles. The condition is genetic, linked to a specific mutation found predominantly in Quarter Horses and related breeds.
How IMM Works at the Genetic Level
IMM is caused by a mutation in the MYH1 gene, which codes for a type of fast-twitch skeletal muscle fiber called type IIx. The specific mutation, known as MYH1E321G, is a single amino acid substitution in the part of the protein responsible for generating force. In affected horses, this altered protein triggers an immune response: the body’s own white blood cells, including several types of lymphocytes, infiltrate the type IIx muscle fibers and attack them as if they were foreign tissue.
The mutation is co-dominant, meaning horses with one copy (heterozygous) and horses with two copies (homozygous) can both be affected, but the severity differs. Homozygous horses produce muscle fibers with significantly higher force output and calcium sensitivity compared to heterozygous or unaffected horses, which likely makes those fibers more conspicuous targets for the immune system.
Which Breeds Are Affected
The MYH1 mutation is found primarily in Quarter Horses, Paints, and Appaloosas. Research from the UC Davis Veterinary Genetics Laboratory found the mutation in roughly 29% of the Quarter Horse population studied. Homozygous horses (carrying two copies) were relatively rare at about 3% of the study population, but the high carrier rate means many breeding decisions unknowingly pass the mutation along.
What Triggers an Episode
Carrying the mutation alone doesn’t guarantee a horse will develop clinical signs. IMM episodes are typically triggered by exposure to or vaccination against Streptococcus equi, the bacterium that causes strangles. This means a horse can carry the mutation for years without incident, then develop dramatic muscle loss after a routine vaccination or after being exposed to a sick horse in the barn. Other respiratory infections may also serve as triggers, though the strangles connection is the best documented.
Recognizing the Signs
The hallmark of IMM is symmetrical muscle wasting along the topline. The gluteal muscles (the large muscles of the hindquarters) lose mass visibly, and the spine and hip bones become prominent. This isn’t the gradual weight loss you’d see from poor nutrition or aging. It happens within one to two days, which is what makes it so alarming to owners who find their horse looking dramatically different almost overnight.
Some horses also show stiffness, reluctance to move, or mild signs of pain, but the muscle atrophy itself is the defining feature. Because the immune attack targets a specific fiber type rather than causing widespread inflammation throughout the body, horses with IMM often remain alert and continue eating normally, which can make the visual transformation even more jarring.
How IMM Is Diagnosed
Diagnosis relies on a combination of clinical signs, genetic testing, and in some cases muscle biopsy. The genetic test for the MYH1 mutation is available through the UC Davis Veterinary Genetics Laboratory and uses validated controls, including horses confirmed positive by biopsy and horses confirmed negative by sequencing, to ensure accuracy. A simple hair or blood sample is all that’s needed.
A positive genetic test tells you the horse carries the mutation, but it doesn’t confirm that a current episode of muscle loss is IMM rather than another condition. Muscle biopsy can provide that confirmation by showing the characteristic pattern of immune cells infiltrating the type IIx fibers. Your veterinarian will decide whether biopsy is necessary based on the clinical picture.
Treatment and Recovery
Because IMM is an autoimmune condition, treatment centers on suppressing the immune response that’s destroying muscle tissue. Corticosteroids are the primary tool, used to calm the inflammatory attack and halt further muscle damage. The goal is to stop the destruction quickly so the body can begin rebuilding.
The frustrating part is the timeline. While muscle loss happens in hours, regrowth takes months. Rebuilding 40% of the topline and hindquarter musculature is a slow process that requires adequate nutrition, particularly sufficient protein and amino acids to support new muscle fiber development. A high-quality forage-based diet supplemented with a protein source containing essential amino acids like lysine and threonine supports recovery, though no single supplement will speed the process dramatically.
Light, controlled exercise as the horse regains strength helps stimulate muscle development, but pushing too hard too early risks setbacks. Most owners should expect a recovery period measured in months rather than weeks.
Recurrence and Long-Term Management
Horses that have experienced one episode of IMM can relapse, particularly if exposed to the same triggers again. This makes management decisions around vaccination important. For horses known to carry the MYH1 mutation, discussing the risks and benefits of strangles vaccination with your veterinarian is essential, since this vaccine is the most commonly reported trigger.
Genetic testing before breeding is also worth considering given the 29% carrier rate in Quarter Horse lines. Breeding two carriers together creates a 25% chance of producing a homozygous foal, which faces the highest risk of severe episodes. Testing breeding stock and making informed pairing decisions is the most effective way to reduce the prevalence of IMM in future generations.